4Filed Aug 4, 8:00 PM ET

Apnimed (APMD) 10% Owner Morningside Buys $5M, Converts Preferred

$APMD · Apnimed, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Apnimed (APMD) 10% Owner Morningside Buys $5M, Converts Preferred

What Happened

  • Morningside Venture Investments Ltd., a 10% owner, completed several IPO-related transactions on Aug 3, 2026. The firm made an open-market/private purchase of 312,500 shares of Apnimed common stock at $16.00 per share for $5,000,000.
  • In addition, Morningside’s convertible securities converted into common stock immediately prior to the issuer’s IPO: 6,840,213 shares resulted from automatic conversion of convertible preferred stock (no cash payment) and 75,624 shares resulted from conversion of a note at a $14.40 conversion price (value reported $1,088,986). The Form 4 also shows related derivative/reclassification entries (including zero-dollar disposals) tied to the internal conversion and reclassification process.

Key Details

  • Transaction date: August 3, 2026; Form 4 filed Aug 5, 2026 (appears timely within the usual two-business-day window).
  • Open-market/private purchase: 312,500 shares at $16.00 = $5,000,000.
  • Note conversion: 75,624 shares at $14.40 = $1,088,986.
  • Preferred conversion: 6,840,213 shares issued via automatic conversion of convertible preferred stock (no cash).
  • Filing shows additional conversion/reclassification entries (e.g., 9,227,454 and 1,088,986.3 shares recorded as $0 disposals) reflecting internal conversions/reclassification, not public sales.
  • Shares owned after the transaction: not explicitly stated in the provided Form 4 excerpt.
  • Footnotes: conversions occurred immediately prior to the IPO; notes converted at a 10% discount to IPO price; directors of Morningside disclaim personal ownership of the securities held by Morningside and its affiliate MVIL, LLC.

Context

  • The large zero-dollar derivative entries reflect automatic conversions and a reclassification of share classes around the IPO (an administrative, Rule 16b‑7 exempt transaction), not secondary market sales.
  • The $5.0M purchase is a direct purchase (a straightforward buy) and is the clearest market-facing bullish signal here; the conversions reflect prior financing converting into public shares.
  • As a 10% institutional owner (not an individual officer), Morningside’s activity is institutional repositioning tied to the company going public rather than a typical insider executive trade.

All statements above are factual summaries of the Form 4 filings and accompanying footnotes; they do not speculate on motivation.